ArticleJAMA2020
Neurology and COVID-19.
Article in JAMA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Lessons from the COVID-19 pandemic for improving outpatient neuropalliative care: A qualitative study of patient and caregiver perspectives.Palliative medicine · 2021Trial
- The seven enigmas of SARS-CoV-2: from the past to the future.Journal of human immunity · 2025Article
- Role of toll-like receptors in post-COVID-19 associated neurodegenerative disorders?Frontiers in medicine · 2025Review
- Assessment of Post-COVID-19 Changes in Brain-Clinical and Imaging Evaluation Using MRI Vessel Wall Imaging and Complementary MRI Methods.Journal of clinical medicine · 2024Article
- The impact of COVID-19 pandemic on patients with Huntington's disease and care-givers: A French survey.eNeurologicalSci · 2024Article
- COVID-19 and the Nervous System from a Cuban Experience.Behavioral sciences (Basel, Switzerland) · 2023Review
- The Spectrum of Vessel Wall Imaging (VWI) Findings in COVID-19-Associated Neurological Syndromes: A Review.Cureus · 2023Review
- Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?Inflammopharmacology · 2023Review
- The Outcomes of COVID-19 Patients with Spontaneous Intracerebral Hemorrhage Comorbidity and the Efficacy of Enoxaparin in Decreasing the Mortality Rate in Them: Single Egyptian Center Report.Journal of personalized medicine · 2022Article
- Leukocyte glucose index as a novel biomarker for COVID-19 severity.Scientific reports · 2022Article
- The blood-brain barrier in health, neurological diseases, and COVID-19.Fundamental research · 2022Review
- Impact of post-COVID conditions on mental health: a cross-sectional study in Japan and Sweden.BMC psychiatry · 2022Article
- Lessons learned from people with neurological diseases at the time of COVID-19: The EFNA-EAN survey.European journal of neurology · 2022Article
- COVID-19 Legacy.Southern medical journal · 2021Review
- Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19.Neurological research and practice · 2021Article
- Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study.BMJ (Clinical research ed.) · 2021Article
- Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium.JAMA network open · 2021Article
- Severity of Chest Imaging is Correlated with Risk of Acute Neuroimaging Findings among Patients with COVID-19.AJNR. American journal of neuroradiology · 2021Article
- Acute confusional state as a prognostic sign of COVID-19 large-vessel occlusion (LVO).BMJ case reports · 2021Article
- Alpha coma in COVID encephalopathy.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2021Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32960246What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.